Gut microbiota: a potential new territory for drug targeting

被引：376
作者：
Jia, Wei [1 ,2 ]
Li, Houkai [1 ,2 ]
Zhao, Liping [1 ,2 ]
Nicholson, Jeremy K. [3 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China
[2] Shanghai Jiao Tong Univ, Inst Syst Biomed, Shanghai 200240, Peoples R China
[3] Univ London Imperial Coll Sci Technol & Med, Dept Biomol Med, Div Surg Oncol Reprod Biol & Anaesthet, Fac Med, London SW7 2AZ, England
来源：
NATURE REVIEWS DRUG DISCOVERY | 2008年 / 7卷 / 02期
关键词：
D O I：
10.1038/nrd2505
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The significant involvement of the gut microbiota in human health and disease suggests that manipulation of commensal microbial composition through combinations of antibiotics, prebiotics and prebiotics could be a novel therapeutic approach. A systems perspective is needed to help understand the complex host bacteria interactions and their association with pathophysiological phenotypes so that alterations in the composition of the gut microbiota in disease states can be reversed. In this article, we describe the therapeutic rationale and potential for targeting the gut microbiota, and discuss strategies and systems-oriented technologies for achieving this goal.
引用
收藏
页码：123 / 129
页数：7
相关论文
共 67 条
  • [1] Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease
    Andoh, Akira
    Fujiyama, Yoshihide
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (28) : 4452 - 4460
  • [2] Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections:: A randomized study
    Arvola, T
    Laiho, K
    Torkkeli, S
    Mykkänen, H
    Salminen, S
    Maunula, L
    Isolauri, E
    [J]. PEDIATRICS, 1999, 104 (05) : art. no. - e64
  • [3] The gut microbiota as an environmental factor that regulates fat storage
    Bäckhed, F
    Ding, H
    Wang, T
    Hooper, LV
    Koh, GY
    Nagy, A
    Semenkovich, CF
    Gordon, JI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (44) : 15718 - 15723
  • [4] BJAMASON IT, 2005, HELICOBACTER, V10, P276
  • [5] Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802
  • [6] Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?
    Brugman, S.
    Klatter, F. A.
    Visser, J. T. J.
    Wildeboer-Veloo, A. C. M.
    Harmsen, H. J. M.
    Rozing, J.
    Bos, N. A.
    [J]. DIABETOLOGIA, 2006, 49 (09) : 2105 - 2108
  • [7] Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs:: a randomised trial
    Chan, FKL
    To, KF
    Wu, JCY
    Yung, MY
    Leung, WK
    Kwok, T
    Hui, Y
    Chan, HLY
    Chan, CSY
    Hui, E
    Woo, J
    Sung, JJY
    [J]. LANCET, 2002, 359 (9300) : 9 - 13
  • [8] Chen Chien-Chang, 2005, Adv Pediatr, V52, P77, DOI 10.1016/j.yapd.2005.03.001
  • [9] Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes
    Chu, FF
    Esworthy, RS
    Chu, PG
    Longmate, JA
    Huycke, MM
    Wilczynski, S
    Doroshow, JH
    [J]. CANCER RESEARCH, 2004, 64 (03) : 962 - 968
  • [10] Pharmaco-metabonomic phenotyping and personalized drug treatment
    Clayton, TA
    Lindon, JC
    Cloarec, O
    Antti, H
    Charuel, C
    Hanton, G
    Provost, JP
    Le Net, JL
    Baker, D
    Walley, RJ
    Everett, JR
    Nicholson, JK
    [J]. NATURE, 2006, 440 (7087) : 1073 - 1077
1234567